At Synthesis, David combines his background in plant biology, cell therapy, and alternative protein technology to identify exceptional technology-focused start-ups and support Synthesis portfolio companies. David previously served as Director of Science and Technology at GFI and in commercial roles within the life science industry. David earned a B.Sc. in biology from the University of California at Berkeley and a Ph.D. in plant developmental cell biology from Utrecht University.
David will be participating on a panel discussion on Biosynthesis: Fermentation and the Future of Flavors, Colors & Sweeteners